Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Neuronetics completes $30mm Series E financing

Executive Summary

First-time backers Pfizer Venture Investments and Polaris Venture Partners have led a $30mm Series E financing for Neuronetics Inc., which creates magnetic pulse-generating devices for major depression. Existing shareholders Investor Growth Capital, New Leaf Venture Partners, InterWest Partners, Three Arch Partners, Quaker BioVentures, and Onset Ventures also participated. Polaris adds a new board member, and a director from Pfizer Venture will join as an observer.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies